Shenzhen New Industries director completes minor share reduction plan

Shenzhen New Industries Biomedical Engineering announced that director Rao Jie, an acting in concert party of a shareholder holding over 5% of the shares, has completed her pre-disclosed share reduction plan as of November 6, 2025. The plan, initially disclosed on September 30, 2025, involved the sale of 1.5m shares, representing 0.1909% of the company's total share capital.

The shares were sold through a combination of block trades and centralized bidding. A block trade on October 31, 2025, accounted for 1.3m shares at an average price of CNY 56.73 per share. Subsequent sales via centralized bidding on November 5 and 6, 2025, involved 168,500 shares at CNY 63.34 and 31,500 shares at CNY 61.80, respectively.

Following this transaction, Rao Jie's total holding, including her acting in concert parties Rao Wei, Hu Yi, and Xu Dinghong, decreased from 16.9570% to 16.7661% of the company's total share capital. The company confirmed that the share reduction was executed in compliance with relevant regulations and does not affect the company's control or ongoing operations.